Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature

A Population-based Study on the Risks of Cervical Lesion and Human Papillomavirus Infection among Women in Beijing, People's Republic of China

(2010) C. Li et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tobacco smoking and regression of low-grade cervical abnormalities

(2010) Koji Matsumoto et al.   CANCER SCIENCE

Progesterone and 17 -Estradiol Enhance Regulatory Responses to Human Papillomavirus Type 16 Virus-Like Particles in Peripheral Blood Mononuclear Cells from Healthy Women

(2010) M. A. Marks et al.   Clinical and Vaccine Immunology

Factors affecting mortality in a large cohort study with special reference to oral contraceptive use

(2010) Martin Vessey et al.   CONTRACEPTION

Issues in cervical cancer incidence and treatment in HIV

(2010) Mark H Einstein et al.   CURRENT OPINION IN ONCOLOGY

Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA

(2010) Gerald Coquillard et al.   GYNECOLOGIC ONCOLOGY

Hormonal contraception and risk of cancer

(2010) D. Cibula et al.   HUMAN REPRODUCTION UPDATE

Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia

(2010) V Gavrić-Lovrec et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Is Higher Prevalence of Cervical Intraepithelial Neoplasia in Women With Lupus Due to Immunosuppression?

(2010) Evandro M. Klumb et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women

(2010) Satoyo Hosono et al.   JOURNAL OF EPIDEMIOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Effect of the Menstrual Cycle and Hormonal Contraceptives on Human Papillomavirus Detection in Young, Unscreened Women

(2010) Channa E. Schmeink et al.   OBSTETRICS AND GYNECOLOGY

Functional Analysis of FOXP3

(2009) Jane H. Buckner et al.   Annals of the New York Academy of Sciences

Malignancy in systemic lupus erythematosus: what have we learned?

(2009) Sasha Bernatsky et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations

(2009) C. Schneider et al.   CLIMACTERIC

Lack of association between cervical dysplasia and IBD: A large case–control study

(2009) C. W. Lees et al.   INFLAMMATORY BOWEL DISEASES

Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17 -Estradiol

(2009) J. Mjosberg et al.   JOURNAL OF IMMUNOLOGY

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

Hormone replacement after gynaecological cancer

(2009) Piksi Singh et al.   MATURITAS

Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients

(2009) Kim A. P. Meeuwis et al.   TRANSPLANT INTERNATIONAL

Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer Risk

(2008) M. M. Madeleine et al.   CANCER RESEARCH

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

(2008) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study

(2008) Harminder Singh et al.   GASTROENTEROLOGY

Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection

(2008) Rika Yamada et al.   JOURNAL OF MEDICAL VIROLOGY

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY